Join George Clinical Cell Gene Therapy (CGT) experts at IGC 2023 on September 8-9 at our booth #A09.

Our experienced CGT team delivers studies based on early risk management plans, scientific integrity, the highest ethical standards, and maximum quality assurance. We can navigate Cell and Gene Therapy trial complexity.

To schedule a time to meet or learn more about how George Clinical can help support your CGT study, please contact our Head of Business Development, APAC Fred Li.

With the theme of “Innovation Drives Development, Integration Leads Transformation”, IGC 2023 will start from 4 major subdivision forums, and especially add “CGT Regulation and Transformation Foresight Forum”. The 4 forums will analyze the new research, new technology, new product innovation, R&D and leading transformation of immune cell therapy (solid tumor, allogeneic universal, non-viral vector), gene therapy (AAV viral vector, ex vivo gene editing, non-viral vector), stem cell therapy (iPSC, MSC, organoid and regenerative medicine), etc., and promote the in-depth exchange and cooperation of national industry, academia, research and medicine. exchange and cooperation, and accelerate the industrial transformation of immunotherapy, gene therapy and cell therapy across the region!